Randomised trial of oral morphine for chronic non-cancer pain
- PMID:8544547
- DOI: 10.1016/s0140-6736(96)90339-6
Randomised trial of oral morphine for chronic non-cancer pain
Abstract
Background: The use of opioid analgesics for chronic non-cancer pain is controversial. Some surveys report good pain relief and improvement in performance while others suggest a poor outcome with a propensity to psychological dependence or addiction.
Methods: We undertook a randomised double-blind crossover study to test the hypothesis that oral morphine relieves pain and improves the quality of life in patients with chronic regional pain of soft tissue or musculoskeletal origin who have not responded to codeine, anti-inflammatory agents, and antidepressants. Morphine was administered as a sustained-release preparation in doses up to 60 mg twice daily and compared with benztropine (active placebo) in doses up to 1 mg twice daily over three-week titration, six-week evaluation, and two-week washout phases. Pain intensity, pain relief, and drug liking were rated weekly and psychological features, functional status, and cognition were assessed at baseline and at the end of each evaluation phase.
Findings: After dose titration in the 46 patients who completed the study, the mean daily doses of drugs were morphine 83.5 mg and benztropine 1.7 mg. On visual analogue scales, the morphine group showed a reduction in pain intensity relative to placebo in period I (p = 0.01) and this group also fared better in a crossover analysis of the sum of pain intensity differences from baseline (p = 0.02). No other significant differences were detected.
Interpretation: In patients with treatment-resistant chronic regional pain of soft-tissue or musculoskeletal origin, nine weeks of oral morphine in doses up to 120 mg daily may confer analgesic benefit with a low risk of addiction but is unlikely to yield psychological or functional improvement.
Similar articles
- A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer.Currow DC, Plummer JL, Cooney NJ, Gorman D, Glare PA.Currow DC, et al.J Pain Symptom Manage. 2007 Jul;34(1):17-23. doi: 10.1016/j.jpainsymman.2006.10.011.J Pain Symptom Manage. 2007.PMID:17601560Clinical Trial.
- Assessment of analgesia in human chronic pain. Randomized double-blind crossover study of once daily repro-dose morphine versus MST continus.Peat S, Sweet P, Miah Y, Barklamb M, Larsen U.Peat S, et al.Eur J Clin Pharmacol. 1999 Oct;55(8):577-81. doi: 10.1007/s002280050675.Eur J Clin Pharmacol. 1999.PMID:10541775Clinical Trial.
- Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain.Allan L, Hays H, Jensen NH, de Waroux BL, Bolt M, Donald R, Kalso E.Allan L, et al.BMJ. 2001 May 12;322(7295):1154-8. doi: 10.1136/bmj.322.7295.1154.BMJ. 2001.PMID:11348910Free PMC article.Clinical Trial.
- Palliative Treatment of Cancer-Related Pain [Internet].Kongsgaard U, Kaasa S, Dale O, Ottesen S, Nordøy T, Hessling SE, von Hofacker S, Bruland ØS, Lyngstadaas A.Kongsgaard U, et al.Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2005 Dec. Report from Norwegian Knowledge Centre for the Health Services (NOKC) No. 09-2005.Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2005 Dec. Report from Norwegian Knowledge Centre for the Health Services (NOKC) No. 09-2005.PMID:29320015Free Books & Documents.Review.
- Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.Pergolizzi J, et al.Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.Pain Pract. 2008.PMID:18503626
Cited by
- [Long-term efficiency of opioid medication in patients with chronic non-cancer-associated pain. Results of a survey 5 years after onset of medical treatment].Maier C, Schaub C, Willweber-Strumpf A, Zenz M.Maier C, et al.Schmerz. 2005 Oct;19(5):410-7. doi: 10.1007/s00482-005-0432-9.Schmerz. 2005.PMID:16133299German.
- Opioid-induced bowel dysfunction: pathophysiology and potential new therapies.Kurz A, Sessler DI.Kurz A, et al.Drugs. 2003;63(7):649-71. doi: 10.2165/00003495-200363070-00003.Drugs. 2003.PMID:12656645Review.
- Relationship Between Opioid Analgesic Prescription and Unemployment in Patients Seeking Acupuncture for Chronic Pain in Urban Primary Care.Chuang E, Gil EN, Gao Q, Kligler B, McKee MD.Chuang E, et al.Pain Med. 2019 Aug 1;20(8):1528-1533. doi: 10.1093/pm/pny169.Pain Med. 2019.PMID:30184213Free PMC article.
- Efficacy of Low-Dose Amitriptyline for Chronic Low Back Pain: A Randomized Clinical Trial.Urquhart DM, Wluka AE, van Tulder M, Heritier S, Forbes A, Fong C, Wang Y, Sim MR, Gibson SJ, Arnold C, Cicuttini FM.Urquhart DM, et al.JAMA Intern Med. 2018 Nov 1;178(11):1474-1481. doi: 10.1001/jamainternmed.2018.4222.JAMA Intern Med. 2018.PMID:30285054Free PMC article.Clinical Trial.
- Responsible prescribing of opioids for the management of chronic pain.Nicholson B.Nicholson B.Drugs. 2003;63(1):17-32. doi: 10.2165/00003495-200363010-00002.Drugs. 2003.PMID:12487620Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical